Can the world’s most valuable pharma company sustain this pace?

The best-selling medicines in history have often left a shadow of research failure behind them

August 14, 2024 Check out STAT+

Sponsored By

Pat Greenhouse/The Boston Globe STAT+ | Eli Lilly's billions: Can the world's most valuable pharma company keep inventing drugs at this pace? Inventing a mega-blockbuster — in this case novel drugs that treat obesity and diabetes — brings its own set of challenges. By Matthew Herper Opinion: Ultra-processed foods: the tobacco of the 21st century? Rise in cancer among people under age 50 correlates to rise in ultra-processed food consumption. FDA should handle UPF like it did tobacco. By Nicholas DeVito STAT+ | Gilead wins U.S. approval for drug to treat autoimmune liver disease Livdelzi is the only drug for primary biliary cholangitis that has demonstrated a statistically significant reduction in severe itch. By Adam Feuerstein Anja Niedringhaus/AP WHO declares mpox outbreak a global health emergency Mpox is caused by a virus in the same family as smallpox, a virus that was declared eradicated in 1980. By Helen Branswell STAT+ | Grail announces layoffs as it looks to push forward blood-based cancer detection test The layoffs were announced the same day as its Q2 financial report, its first since it was divested by DNA sequencing juggernaut Illumina in June. By Jonathan Wosen STAT+ | Illumina lays out plan to boost growth by helping scientists interpret sequencing data Illumina CEO Jacob Thaysen made clear the sequencing giant is returning to its traditional role of creating instruments for researchers. By Jonathan Wosen LUDOVIC MARIN/AFP via Getty Images Sudden cardiac arrest requires luck to survive. Scientists hope to turn those odds around Advances include a refined tool to find cardiovascular risk factors, genetic discoveries and potential cell-based therapies. By Elizabeth Cooney

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser